Apoptosis and Senescence in Localized Prostate Cancer Tissues Treated With HDR-BT Boost With Radiotherapy (EBRT) and ADT

被引：0
|
作者：
Chebra, I. [1 ]
机构：
[1] CHU Quebec, Quebec City, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2518
引用
收藏
页码：E258 / E258
页数：1
相关论文
共 50 条
  • [41] Dose integration of whole breast EBRT and HDR interstitial BT boost in early-stage breast cancer
    Frohlich, G.
    Meszaros, N.
    Smanyko, V.
    Polgar, C.
    Major, T.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1362 - S1362
  • [42] SINGLE FRACTION HDR BRACHYTHERAPY AS ANTICIPATED BOOST IN LOCALIZED PROSTATE CANCER
    Cerrotta, A.
    Fallai, C.
    Carrara, M.
    Borroni, M.
    Villa, S.
    Bedini, N.
    Garcia, M.
    Maucione, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S288 - S289
  • [43] Long-term chronic toxicity profile of a dose escalating hypofractionated pelvic external beam radiation therapy (EBRT) with a high dose rate Brachytherapy (HDR-BT) boost for intermediate and high risk prostate cancer
    Marvin, K.
    Wallace, M.
    Ghilezan, M.
    Gustafson, G.
    Kestin, L.
    Sebastian, E.
    Martinez, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S95 - S96
  • [44] Combined use of goldmarkers for setup in fractionated HDR brachytherapy (BT) and organtracking during EBRT of prostate cancer
    Aebersold, DM
    Kolotas, C
    Isaak, B
    Thalmann, G
    Vetterli, D
    Kernmerling, L
    Behrensmeier, F
    Mini, R
    Greiner, RH
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 101 - 101
  • [45] CT-IMAGE BASED INTERSTITIAL HDR BRACHYTHERAPY (HDR-BT) BOOST IN THE CONSERVATIVE TREATMENT OF STAGE I-II BREAST CANCER
    Kubaszewska, M.
    Dymnicka, M.
    Skowronek, J.
    Chichel, A.
    Kanikowski, M.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S196 - S196
  • [46] HDR-BT and SBRT in prostate cancer: results from a prospective phase II trial NCT04523896
    Buchser Garcia, D.
    Bilbao, A.
    Marban, M.
    Cacicedo, J.
    Perez, F.
    Valverde, I.
    Espinosa, J. M.
    Santos, B.
    Casquero, F.
    Gomez-Iturriaga, A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S516 - S516
  • [47] HDR BRACHYTHERAPY OF PROSTATE CANCER AS A BOOST AFTER EXTERNAL BEAM RADIOTHERAPY
    Kanikowski, M.
    Skowronek, J.
    Kubaszewska, M.
    Chichel, A.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S324 - S324
  • [48] DOES EXIST DEPENDENCE OF DOSE VALUES IN ORGANS OF RISK (OAR) AND PROGNOSTIC FACTORS UNDER HDR BRACHYTHERAPY (HDR-BT) OF PROSTATE CANCER?
    Skowronek, J.
    Chichel, A.
    Kanikowski, M.
    Zwierzchowski, G.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S51 - S51
  • [49] SEVENTEEN YEARS EXPERIENCE OF EBRT PLUS HDR BRACHYTHERAPY BOOST IN HIGH-RISK LOCALIZED PROSTATE CANCER PATIENTS: A COMPETING RISKS ANALYSIS
    Carignan, Damien
    Despres, Philippe
    Magnan, Sindy
    Froment, Marie-Anne
    Foster, William
    Aubin, Sylviane
    Lavallee, Marie-Claude
    Lacroix, Frederic
    Cantin, Audrey
    Poulin, Eric
    Martin, Andre-Guy
    Vigneault, Eric
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S9 - 510
  • [50] THE IMPACT OF ANDROGEN-DEPRIVATION THERAPY ON CERAMIDES, A POTENTIAL BIOMARKER OF OUTCOMES OF PROSTATE CANCER FOR PATIENTS TREATED WITH EBRT AND HDR BRACHYTHERAPY BOOST
    Carignan, Damien
    Bourgeois, Marine
    Foster, William
    Martin, Andre-Guy
    Paris, Francois
    Vigneault, Eric
    RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S77 - S78
12345